In Vitro Characterization of Astaxanthin Biosynthetic Enzymes*

(Received for publication, February 6, 1996, and in revised form, December 19, 1996)

Paul D. Fraser Dagger , Yutaka Miura and Norihiko Misawa

From the Central Laboratories for Key Technology, Kirin Brewery Co., Ltd., Kanazawa-ku, Yokohoma-shi, Kanagawa 236, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Escherichia coli strains expressing the marine bacteria (Agrobacterium aurantiacum and Alcaligenes sp. strain PC-1) astaxanthin biosynthetic genes (crtZ and W), Haematococcus pluvialis bkt, and Erwinia uredovora crtZ genes were used for in vitro characterization of the respective enzymes. Specific enzyme assays indicated that all of the enzymes are bifunctional, in that the CrtZ enzymes formed zeaxanthin from beta -carotene via beta -cryptoxanthin, as well as astaxanthin from canthaxanthin via phoenicoxanthin (adonirubin). The BKT/CrtW enzymes synthesized canthaxanthin via echinenone from beta -carotene and 4-ketozeaxanthin (adonixanthin) with trace amounts of astaxanthin from zeaxanthin. Comparison of maximum catalytic activities as well as selectivity experiments carried out in the presence of both utilizable substrates indicated that the CrtZ enzymes from marine bacteria converted canthaxanthin to astaxanthin preferentially, whereas the Erwinia CrtZ possessed a favorability to the formation of zeaxanthin from beta -carotene. The CrtW/BKT enzymes were not so defined in their substrate preference, responding readily to fluctuations in substrate levels. Other properties obtained indicated that the enzymes were strictly oxygen-requiring; and a cofactor mixture of 2-oxoglutarate, ascorbic acid, and Fe2+ was beneficial to activity. Based on enzymological data, a predicted pathway for astaxanthin biosynthesis is described, and it is proposed that CrtZ-like enzymes be termed carotenoid 3,(3')-beta -ionone ring hydroxylase and CrtW/BKT carotenoid 4,(4')-beta -ionone ring oxygenase.


INTRODUCTION

Astaxanthin (3,3'-dihydroxy-beta ,beta -carotene-4,4'-dione) is the most commonly found carotenoid pigment in marine animals (1). It is responsible for the red/pink coloration of crustaceans (1), shellfish (2), and the flesh of salmonoids (3). Despite high endogenous levels, these marine animals do not possess the ability to synthesize astaxanthin or other carotenoid pigments de novo. Instead carotenoid pigments must be acquired via their diet (4). Industrially, astaxanthin has been exploited as a feed supplement for cultured fish and shellfish (5-7). Other diverse biological functions of astaxanthin include an involvement in cancer prevention (8), enhancer of immune responses (9), and a free radical quencher (10, 11). It is evident, therefore, that astaxanthin is a molecule with potential both to the pharmaceutical and food industries.

Astaxanthin belongs to the class of compounds known as xanthophylls. These are carotenoids modified with oxygen-containing functional groups. Xanthophylls are found universally in chloroplast-containing plant tissues. However, the biosynthesis of astaxanthin is limited in a virtually exclusive manner to microorganisms, for example, the yeast Phaffia rhodozyma (12), the freshwater alga Haematococcus pluvialis (13) and the marine bacteria Agrobacterium aurantiacum and Alcaligenes sp. strain PC-1 (14). Recently the genes involved in the formation of astaxanthin and its intermediates have been isolated and functionally characterized in vivo by complementation, providing the first insight into the biosynthetic route (15). The pathway proposed (Fig. 1) is based on the lack of enzyme specificity surmised from complementation studies (15). The hydroxylation of beta -carotene at positions 3 and 3' on the beta -ionone ring forming zeaxanthin via beta -cryptoxanthin is mediated by the product of the gene designated crtZ, which has been isolated from Erwinia species (16, 17) and marine bacteria (15). The direct conversion of methylene to keto groups at positions 4 and 4' on the beta -ionone ring forming canthaxanthin via echinenone are reactions performed by the gene product encoded by the crtW gene from marine bacteria (18) and bkt gene of H. pluvialis (19). A comparison of the deduced amino acid sequences indicates the existence of 90% identity between the marine bacteria A. aurantiacum and Alcaligenes PC-1 CrtZ, which in turn show 54% identity with the Erwinia species. The CrtW proteins possess a 75% identity among the marine bacteria species, whereas a 37% identity is evident when compared with the BKT gene product of H. pluvialis. When combinations of the gene products responsible for the introduction of the hydroxyl moieties at positions 3,3' and formation of keto groups at 4,4' positions on the beta -ionone ring are expressed in Escherichia coli, astaxanthin as well as substantial quantities of various intermediates are synthesized (15). Because of the limitations of in vivo complementation, the bifunctional character of the CrtZ and/or CrtW type gene products has not been ascertained conclusively. Thus it remains unclear whether CrtZ can convert canthaxanthin to astaxanthin via phoenicoxanthin (adonirubin) or CrtW can convert zeaxanthin to astaxanthin via 4-ketozeaxanthin (adonixanthin).


Fig. 1. Postulated astaxanthin biosynthetic pathway deduced from in vivo complementation studies (15).
[View Larger Version of this Image (28K GIF file)]


At present no specific in vitro assay systems, cofactor requirements, or properties of the enzymes originating from an astaxanthin-forming organism have been reported. Advances in carotenoid enzymology have, however, been hindered by the practical difficulties associated with their assay (20, 21). The heterologous expression of the recently isolated astaxanthin biosynthetic genes in E. coli has provided a valuable opportunity to study the respective enzymes. In this article the in vitro characterization of the marine bacteria CrtZ and CrtW enzymes specific to astaxanthin biosynthesis are reported for the first time as well as a comparison with the Erwinia CrtZ and Haematococcus BKT.


EXPERIMENTAL PROCEDURES

Plasmids

Plasmids pCAR16Delta crtX and pCAR25Delta crtX, corresponding to pCAR16delB and pCAR25delB (16), contain the Erwinia uredovora genes for the synthesis of beta -carotene and zeaxanthin, respectively. pACCAR16Delta crtX has been described (18). pCRT-Z containing the E. uredovora crtZ gene was constructed by inserting the SphI(5599)-EcoRI(6505) fragment of pCAR25 (16) into the EcoRI-SphI site of pUC18. Plasmids pAK916 and pAK96NK, which contain the A. aurantiacum crtW and crtZ genes, respectively, were described previously (15). pPC17-3 (18) and pPC13 (15) carried the Alcaligenes sp. strain PC-1 crtW and crtZ genes, respectively. Plasmid pUCBKT containing the H. pluvialis bkt gene was constructed by polymerase chain reaction using plasmid pHP51 (19) as a template, where ATG at nucleotide position 264 (19) was placed next to the HindIII site of pUC19 to form a fusion protein with the amino terminus of beta -glucosidase as follows.
<UP>                                                      264</UP>
<UP>——— ATG ACC ATG ATT ACG CCA AGC TTG ATG CCA TCC GAG TCG ———</UP>
<UP>———Met    Thr    Met    Ile    Thr    Pro    Ser    Leu    Met    Pro    Ser    Glu    Ser———</UP>

Organisms and Culture Conditions

The E. coli strains were grown in 2 × YT medium (22) containing the appropriate additions as described below. In all cases an initial overnight culture (5 ml) was prepared from a glycerol stock. An aliquot constituting 1% by volume of the fresh culture medium was used to inoculate cultures for induction. These cultures contained 0.1 mM isopropyl 1-thio-beta -D-galactopyranoside and the following antibiotics depending on the recombinant strain. Strains used and antibiotic requirements follow. E. coli JM109 containing plasmids pCAR16Delta crtX, pCAR25Delta crtX, pCRT-Z, pAK916, pAK96NK, pPC17-3, pPC13, and pUCBKT required ampicillin at a final concentration of 150 µg/ml. E. coli JM101 containing pACCAR16Delta crtX and pAK916, which synthesized canthaxanthin (18), required ampicillin (150 µg/ml) and chloramphenicol (30 µg/ml). All E. coli strains were grown at 30 °C and shaken at 200 rpm. Marine bacteria A. aurantiacum and Alcaligenes PC-1 were grown in Sakagachi flasks (Eagleglass, Tokyo) containing 150 ml of marine broth (Difco). Culture vessels were shaken (164 rpm) at 20 °C for 4 days under diffuse light.

Preparation of Cell Extracts

Recombinant E. coli extracts were prepared from cells induced for 4 or 6 h. Cells were collected by centrifugation at 6,000 × g. Pelleted cells were placed on ice and resuspended in 100 mM Tris-HCl, pH 8.0, containing 1 mM dithiothreitol, protease mixture (0.1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml pepstatin) as well as 5% glycerol v/v. The suspension was passed through a French press cell at a internal pressure of 500 p.s.i. DNase (50 µg) was added to the broken extract, and the mixture was incubated on ice for 30 min. The crude extract was centrifuged at 10,000 × g to remove cell debris. When determining cofactor requirements the supernatant was desalted with a PD10 column (Pharmacia Biotech Inc.) in 100 mM Tris-HCl, pH 8.0, containing 1 mM dithiothreitol.

Incubation Conditions

Incubations were carried out in a total volume of 800 µl. Typically 400 µl of the substrate extract of E. coli producing beta -carotene, canthaxanthin, or zeaxanthin was added (the precise volume varied depending on the quantity of substrate supplied). An equal volume of the E. coli extract to be analyzed was also added. The remaining 200 µl was buffered with 0.4 M Tris-HCl, pH 8.0, containing 1 mM dithiothreitol, 0.1% v/v Tween 60, 3 mM ATP, 0.5 mM FeSO4, 0.5 mM 2-oxoglutarate, 5 mM ascorbic acid. The presence of 1 mg/ml catalase was optional. The mixture was incubated by shaking in the dark for 4 h at 30 °C. When performing incubations with both utilizable substrates the mixture could be boiled for 30 s to remove any endogenous activities. Incubations were terminated by the addition of methanol and stored at -70 °C under an atmosphere of nitrogen. Anaerobic incubations were performed in Thunberg tubes (23). Extracts and incubation mixture were degassed under vacuum then purged with nitrogen gas prior to sealing. Control incubations were performed simultaneously in all experiments. They were identical apart from the presence of an E. coli extract from a non-crtZ or crtW expressing strain, as well as incubations containing heat-denatured (boiled 1 min) enzyme preparations.

Extraction and Analytical Methods

Carotenoid standards were extracted and purified from recombinant E. coli strains and A. aurantiacum using general carotenoid methodology as described (24). Products and substrates from the in vitro incubations were extracted with 10% (v/v) diethyl ether in petroleum ether 40-60 °C (3 volumes). After mixing, a partition was formed by centrifugation at 3,000 × g for 5 min at 4 °C. The organic phase was removed and aqueous phase reextracted with the same solvent. The remaining aqueous phase was further reextracted with chloroform (2 volumes). The organic extracts were pooled and brought to dryness under a stream of nitrogen.

Carotenoids formed in vitro were separated by HPLC1 on a reversed phase C18 column (Nova-pak HR 6 µ C18, 3.9 × 300 mm, Waters) using an isocratic mobile phase of acetonitrile/methanol/isopropyl alcohol (90:6:40, v/v/v). On-line photodiode array detection enabled peak identification by comparison of spectral data with authentic standards (24). Retention times and lambda max, respectively, are as follows: astaxanthin, 5.31 min, 480 nm; 4-ketozeaxanthin, 5.96 min, 465 nm; phenicoxanthin, 6.61 min, 475 nm; zeaxanthin, 7.09 min, 456 nm; canthaxanthin, 9.05 min, 475 nm; beta -cryptoxanthin, 20.3 min, 452 nm; echinenone, 22 min, 460 nm; beta -carotene 60.6 min, 456 nm. Quantification of carotenoids was achieved by injecting known amounts of carotenoid standards to generate a standard curve. In addition, further confirmation of the amount eluting and detected on-line was performed using the method devised by Sandmann (35). The detection limit of HPLC-photodiode array detection system was 0.0003 absorbance units corresponding to 0.5 pmol/h/mg of protein enzyme activity. Below this level novel peaks were detectable having the correct retention time, but definitive spectral data were difficult to derive and therefore are referred to as trace levels.

Protein and Other Determinations

Protein present in E. coli extracts was estimated using the Bio-Rad protein assay dye reagent protocol following the manufacturer's instructions. Enzyme activity was expressed as pmol formed per h/mg of protein in all cases. When determining the in vivo rate of carotenoid formation carotenoid-synthesizing E. coli cultures were induced and time points taken at 1-h intervals. In vivo and in vitro comparisons were made between cells induced for the same time period in the case of recombinant strains.


RESULTS AND DISCUSSION

Specific Determination of CrtZ and W/BKT Enzyme Activities

Substrates were supplied in the form of extracts prepared from recombinant E. coli strains accumulating beta -carotene, zeaxanthin, and canthaxanthin in the all-trans configuration. This procedure overcame difficulties experienced when introducing carotenoids into aqueous incubation mixtures. All varieties of the CrtZ enzymes formed zeaxanthin from beta -carotene via the monohydroxylated compound beta -cryptoxanthin. The intermediate beta -cryptoxanthin was detectable at significant levels (20-40%) as shown in Fig. 2A. When canthaxanthin was supplied to the CrtZ enzymes astaxanthin was formed via phoenicoxanthin in all cases. Astaxanthin was the predominant product constituting (>70%) of the total products (Fig. 2B). Canthaxanthin was the predominant (63-68%) product synthesized by CrtW/BKT from beta -carotene; significant amounts (30-35%) of its mono-keto intermediate echinenone were also detected. The ratio of canthaxanthin to echinenone was independent of species (Fig. 2C). When supplied with zeaxanthin, CrtW and BKT preparations only formed trace levels (0.5 pmol/h/mg of protein) of astaxanthin, but 4-ketozeaxanthin was formed predominantly by the enzyme from all varieties (Fig. 2D). Why the CrtW and BKT enzymes were unable to catalyze the conversion of 4-ketozeaxanthin to astaxanthin from the initial substrate zeaxanthin efficiently is difficult to explain. It is possible that the experimental conditions were not optimal. However, in vivo 4-ketozeaxanthin can accumulate (up to 50% of the total carotenoid content) in recombinant E. coli strains forming ketocarotenoids (15), and in the marine bacteria it is often more predominant than astaxanthin (14). Such findings correlate with the in vitro data reported in this study and could suggest that the formation of the 4' keto group on 3,3'-hydroxylated beta -ionone ring-containing carotenoids is prevented if prior keto group formation at position 4 has occurred.


Fig. 2. Products formed by CrtZ enzymes from A. aurantiacum, Alcaligenes sp. strain PC-1, and E. uredovora with the substrates beta carotene (panel A) and canthaxanthin (panel B). Products formed by CrtW from A. aurantiacum, Alcaligenes sp. strain PC-1 and BKT of H. pluvialis with the substrates beta -carotene and zeaxanthin are shown in panels C and D, respectively. Determinations were performed with crude extracts of E. coli (protein content 500 µg). Cofactors and incubation conditions are as given under "Experimental Procedures." Substrates were supplied at 2 µg. Agro, Al, and Erw refer to A. aurantiacum, Alcaligenes PC-1, and E. uredovora, respectively. CrtZ reactions using beta -carotene as the substrate are shown in panel A, mean ± S.E. (n = 3) and with canthaxanthin as substrate in panel B, mean ± S.E. (n = 7). CrtW/BKT conversions using beta -carotene are shown in panel C, mean ± S.E. (n = 5), and zeaxanthin as substrate in panel D, mean ± S.E. (n = 3).
[View Larger Version of this Image (54K GIF file)]


Reaction products were separated by HPLC and identified with an on-line photodiode array detector, from which spectral data could be derived (described under "Experimental Procedures"). Comparison with authentic standards enabled conclusive identification by cochromatography and comparative spectral data. In all cases the CrtZ/W and BKT reaction products were of the all-trans configuration and constituted novel compounds not present in control samples. Controls were performed with both extracts of E. coli strains not harboring astaxanthin-forming genes and heat-denatured extracts. Some compounds present at low levels did occur in the controls and were also detectable in the experimental incubations, but they did not cochromatogram with the CrtZ/W and BKT reaction products and were spectrally unrelated. Presumably these compounds were derived from the substrates due to nonspecific oxidation. Thus it can be confirmed that the enzymes CrtZ/W of marine bacteria, CrtZ of Erwinia, and BKT of Haematococcus are bifunctional in their activity. Hydroxylation of carotenoid beta -ionone rings by CrtZ can be performed specifically at the 3,3' positions regardless of the presence of previous keto group formation at positions 4,4'. Although the formation of keto groups by CrtW/BKT is specific at positions 4,4' on the beta -ionone rings retrospective of previous 3,3' hydroxylation, it must be stated that the mono-keto reaction product accumulates if prior 3,3' hydroxylation has occurred. In this study, we have only used carotenoids containing beta -ionone rings as they are the precursors involved in astaxanthin formation. It would be interesting to ascertain whether the substrate specificity and product diversity would extend to epsilon -ring cyclic carotenoids or even acyclic carotenoids.

In Table I the maximum catalytic activities are presented. These data indicate that compared with the Erwinia CrtZ the marine bacteria enzymes possess greater (e.g. A. aurantiacum, 10-fold) ability to convert canthaxanthin to astaxanthin. In contrast, the Erwinia enzyme shows greater (e.g. 10-fold compared with Alcaligenes) activity for the conversion of beta -carotene to zeaxanthin than canthaxanthin to astaxanthin. Of the CrtZ enzymes the marine bacterium A. aurantiacum possessed the greatest activity. Comparison of CrtW/BKT activities using beta -carotene as substrate indicated that the Alcaligenes PC-1 CrtW was about 2-fold greater than the other varieties which were similar in activity (Table I). 4-Ketozeaxanthin was formed from zeaxanthin at a similar rate by all of the enzymes examined.

Table I.

In vitro activities of CrtZ (I) and CrtW/BKT (II) enzymes

Incubations were performed at 30 °C, in dark, aerobic conditions, for 3 h. Substrate levels (1.5 µg) and protein content (500 µg) were standardized. Incubations contained the following cofactors ATP (3 mM), FcSO4 (0.5 mM), 2-oxoglutarate (0.5 mM), and ascorbic acid (5 mM) as described under "Experimental Procedures." Data represent the means ± S.E. (n = 5).
Enzyme source (recombinant E. coli strain) Gene product assayed Specific enzyme activity
 beta -Carotene right-arrow zeaxanthin Canthaxanthin right-arrow astaxanthin

pmol/h/mg protein
I. JM109 (pAK96NK) A. auratiacum CrtZ 9  ± 1.0 60  ± 8.0
  JM109 (pPC13) Alcaligenes PC-1 CrtZ 3.4  ± 0.9 28  ± 4.0
  JM109 (pCRT-Z) Erwinia CrtZ 37  ± 6.0 6  ± 1.3
  JM109 0 0
  JM109 (pAK96NK/pPC13/pCRT-Z) Heat-denatured CrtZ 0 0
 beta -Carotene right-arrow canthaxanthin Zeaxanthin right-arrow 4-ketozeaxanthin

pmol/h/mg protein
II. JM109 (pAK916) A. auratiacum CrtW 5  ± 0.7 12  ± 2.0
   JM109 (pUCBKT) Hematococcus BKT 5  ± 1.0 10  ± 3.0
   JM109 (pPC17-3) Alcaligenes PC-1 CrtW 12  ± 3.0 9  ± 3.0
   JM109 0 0
   JM109 (pAK96NK/pPC13/pCRT-Z) Heat-denatured CrtW/BKT 0 0

The in vivo rate of carotenoid formation in recombinant strains synthesizing zeaxanthin (CrtZ), canthaxanthin (CrtW), and astaxanthin (CrtZ+ W/BKT) as well as the marine bacteria were determined as 5.3 ± 1.9, 1.8 ± 0.2, 2.95 ± 0.95, and 3.1 ± 0.7 µg/g dry weight/h, respectively. Corresponding to typical in vitro rates for CrtZ enzymes of 2.5 µg/g dry weight/h (mean from typical experiment) and CrtW/BKT 0.83 µg/g dry weight/h (mean from typical experiment). The in vitro rates for CrtZ and W/BKT, respectively, are 47 and 46% of the in vivo rate. To our knowledge no previous data have been reported comparing in vivo and vitro rates of carotenoid formation. Other enzymes involved in terpenoid biosynthesis have been compared with their in vivo biosynthetic capacity. In these instances it was found that the enzymes camphor hydroxylase, abietadiene and abietadienol hydroxylase only constituted 10-20% (25) or 1% (26) of the in vivo capacity. Considering that carotenoids like other terpenoids are hydrophobic (preventing effective use in aqueous solution), easily degraded, oxidized, and prone to isomerization, it is not surprising that in vitro rates are typically a poor reflection of their in vivo counterparts. Taking these facts into account along with the strong analogy between qualitative product formation in vitro and in vivo, we believe it is justified that at present the in vitro system described represents a creditable representation of the in vivo situation.

Oxygen Dependence of CrtZ- and W/BKT-catalyzed Reactions

The absence of oxygen on carotenoid hydroxylation and oxygenation in vitro was assessed. Table II shows experimental data obtained with the A. aurantiacum enzymes using the substrates beta -carotene, canthaxanthin, and zeaxanthin independently. It was evident that all catalyzed reactions studied were oxygen-dependent, each having a similar degree of sensitivity to the absence of oxygen. Phoenicoxanthin was formed at a rate of 17.0 pmol/h/mg of protein, quantitatively similar to the aerobic rate of 22.0 pmol/h/mg of protein. However, when the levels of phoenicoxanthin formed aerobically and aerobic are compared in a qualitative manner with respect to their proportion of total CrtZ products it is significant that phoenicoxanthin the monohydroxylated product is the predominant product compared with astaxanthin (dihydroxylated) under aerobic conditions. When the aerobic CrtZ activity was reduced to a total rate quantitatively similar to the anaerobic level, qualitatively astaxanthin remained the principal product. Thus, predominance of phoenicoxanthin in the anaerobic incubation was a finding specific to those conditions. Similar findings of mono-ketolated product accumulation were observed with CrtW and beta -carotene as substrate. It was impossible to observe any difference in the product profile formed from zeaxanthin by CrtW/BKT as the activity was not detectable, and as stated previously 4-ketozeaxanthin is the principal product of this reaction. From the experimental data it can be concluded that oxygen is involved in all of the reactions performed by the CrtZ and W enzymes from marine bacteria; this also reflects the situation found with BKT and Erwinia CrtZ (data not shown). At present we cannot conclusively ascertain whether the oxygen moieties present in the carotenoid molecule resulting from enzymatic synthesis are derived directly from molecular oxygen or if oxygen is indirectly utilized in the catalysis. These findings are the first in vitro evidence that the enzymes involved in astaxanthin biosynthesis are oxygen-dependent, and they complement previous in vivo studies described for zeaxanthin formation by Flavobacterium species (27), xanthophyll synthesis in leaf tissue (28), astaxanthin accumulation in P. rhodozyma (29), and xanthophyll formation in marine bacteria (34). The changing pattern of products formed with reduced oxygen levels suggests that its presence or absence could also play a crucial regulatory role over product formation and could possibly be influenced by environmental conditions.

Table II.

Oxygen dependence of CrtZ- and CrtW-mediated reactions

The A. aurantiacum CrtZ/W are showed as representative examples of the determination of oxygen dependence. Incubations contained ATP (3 mM), FeSO4 (0.5 mM), 2-oxoglutarate (0.5 mM), and ascorbic acid (5 mM) as described under "Experimental Procedures." Crude extracts contained 450 µg of protein. Data represent means ± S.E. (n = 8) of a typical experiment. Activities represent total products formed, e.g. in the case of CrtZ with the substrate beta -carotene the products are zeaxanthin + beta -cryptoxanthin. Control experiments were carried out under identical conditions except that E. coli extracts not harboring CrtZ/W and boiled extracts were used.
Gene product assayed Substrate Activity
% Inhibition
Aerobic Anaerobic

pmol/h/mg protein
CrtZ  beta -Carotene 22  ± 0.9 4  ± 2.0 76
CrtZ Canthaxanthin 219  ± 23.0 24  ± 7.0 88
CrtZ (heat-denatured)  beta -Carotene/canthaxanthin 0 0
CrtW  beta -Carotene 22  ± 5.0 1  ± 0.5 96
CrtW Zeaxanthin 39  ± 0.2 0 100
CrtW (heat-denatured)  beta -Carotene/canthaxanthin 0 0

Effect of Cofactors on CrtZ- and W/BKT-catalyzed Reactions

In the absence of any exogenously added cofactors significant activity (20%) was detectable. Therefore there was no absolute requirement for cofactors using these enzyme preparations. The addition of the dinucleotides NAD+, NADP+ and flavins FAD, FMN (at a concentration of 1 mM) as well as divalent ions Mg2+ and Mn2+ to the incubations individually and in combination had no stimulatory effect. In fact they were often inhibitory. The presence of NADPH+ (1 mM) did yield some elevation (2.5-fold) in activity. These findings were consistent among the marine bacteria CrtZ/W, Erwinia CrtZ and BKT enzyme.

Combinations of cofactors used for typical monooxygenase (30) or dioxygenase (31) reactions were tested subsequently. The monooxygenase cofactors consisted of FAD, NADPH+, and ATP. This cofactor combination increased the activity of CrtW and Z about 2.5- and 1.5-fold greater than the control, respectively. When the dioxygenase mixture (Fe2+, 2-oxoglutarate, ascorbic acid, and catalase) was used, far greater stimulation in activity was found, particularly in the case of CrtZ, where about a 6-fold elevation was experienced. CrtW activity was also increased significantly (4-fold). Based on the observed stimulation in activities, a detailed analysis of the components was made. A similar profile in activities was observed between the CrtZ/W-catalyzed reactions as shown in Table III. The presence of Fe2+, 2-oxoglutarate, and ascorbic acid in combination was responsible for the greatest enzymatic activity; however, all incubations containing Fe2+ possessed an activity higher than the control value, indicating that Fe2+ was the most influential effector. A series of control experiments confirmed that this cofactor mixture could not perform these conversions without the presence of the enzymes. Their presence enhanced specific 3,3' hydroxylation by CrtZ' or 4,4' oxygenation by CrtW. Comparison between the gene sequences encoding the marine bacteria CrtZ and W, E. uredovora and Erwinia herbicola as well as bkt revealed a number of conserved histidine residues in a formation consistent with reported Fe2+ binding motifs (HX3H, HX2HH, or HX2HH). Such motifs are characteristic of enzymes containing non-heme iron such as membrane-bound fatty acid desaturases (32). Fig. 3 shows the alignment of the postulated Fe2+ binding motifs present in the CrtZ genes from marine bacteria and Erwinia species. Three conserved Fe2+ motif regions exist occurring at H25X4H, H38X2HH, and H123X2HH. In the case of BKT and the CrtW enzymes of marine bacteria such motifs occur at H130X3H, H168X2HH as well as an overlapping conserved sequence between H289X3H and H294X2HH. Thus both biochemical and molecular data suggest that Fe2+ is a cofactor involved in the catalysis performed by these enzymes. Of the other cofactors (2-oxoglutarate and ascorbic acid) present in the optimal combination no independent stimulatory role was witnessed. Perhaps their function may be as oxidizable cosubstrates, which generate a reactive ferryl ion in the process. Such a mechanism would be similar to the gibberellin oxidases and hydroxylases (31). However, in the experimental system described in this article it is likely that ascorbic acid is substituting for a genuine cosubstrate as ascorbic acid is not present endogenously in E. coli. Purification of these enzymes will hopefully enable determination of the precise role performed by these postulated cofactors as well as in vitro mutagenesis of the postulated Fe2+ binding sites.

Table III.

Influence of Fe2+, ascorbic acid, 2-oxoglutarate, and catalase on activity

The amount of substrate used and protein content of the extracts were standardized at 2 µg and 300 µg, respectively. The basal activity without the presence of additional cofactors (20% of the maximum) has been subtracted from all determinations for clarity. The greatest rate determined for each reaction is shown as 100%; all other determinations are relative to this value (see footnotes to table for precise values). Basic mixture is described under "Experimental Procedures" without the stated additions. JM109 extract is a control extract not expressing CrtZ/W. All data are the mean of duplicate or triplicate incubations from a typical experiment.
Cofactor additions CrtZ
CrtW
 beta -Carotene Canthaxanthin  beta -Carotene Zeaxanthin

% relative activity % relative activity
Basic mixture 0 0 0 0
+Fe2+, ascorbic acid, 2-oxoglutarate, catalase 100a 43 70 100b
+Fe2+, ascorbic acid, 2-oxoglutarate 16 100c 100d 59
+Fe2+, ascorbic acid 4 63 0 74
+Fe2+ 7 63 0 74
+Fe2+, 2-oxoglutarate 14 7 10 26
+Fe2+, catalase 12 7 0 19
+Fe2+, 2-oxoglutarate, catalase 9 63 0 15
+Ascorbic acid, 2-oxoglutarate, catalase 2 0 0 0
+Ascorbic acid, 2-oxoglutarate 0 0 0 0
+Ascorbic acid, catalase 0 0 0 0
+Ascorbic acid 0 0 0 0
+2-Oxoglutarate, catalase 0 0 0 0
+2-Oxoglutarate 0 0 0 0
+Catalase 0 5 0 0
+Fe2+, ascorbic acid, 2-oxoglutarate, catalase, heat-denatured CrtZ/W 0 0 0 0
+Fe2+, ascorbic acid, 2-oxoglutarate, catalase, JM109 extract 0 0 0 0

a 33.3 pmol/h/mg of protein.
b 150 pmol/h/mg of protein.
c 417 pmol/h/mg of protein.
d 92 pmol/h/mg of protein.


Fig. 3. Alignment of A. aurantiacum (Aa), Alcaligenes PC-1 (Al) CrtZ/W, E. uredovora (Eu) and E. herbicola (Eh), and H. pluvialis BKT protein sequences. Conserved iron binding motifs are underlined. Bold type indicates conserved residues among all sequences.
[View Larger Version of this Image (16K GIF file)]


Selectivity of Substrate Utilization by CRTW/Z

To investigate the preference of one substrate above the other by these bifunctional enzymes experiments were designed whereby both utilizable substrates were added to the enzyme preparation simultaneously, initially in an equal ratio. The resulting activities were calculated for the individual reactions rates then expressed as the percent of the total activity. The marine bacteria CrtZ enzymes showed that canthaxanthin was the favored substrate for conversion, 36-fold in the case of A. aurantiacum and 6-fold in the case of Alcaligenes PC-1. The E. uredovora CrtZ in contrast showed a 5-fold preference for beta -carotene as the substrate to zeaxanthin (Fig. 4A). The CrtW enzymes and BKT gene product were less conclusive in their selectivity with both BKT and A. aurantiacum possessing about a 2-fold preference for zeaxanthin as the substrate for 4-ketozeaxanthin formation. Alcaligenes CrtW, however, showed no significant favorability to zeaxanthin as the principal substrate for conversion (Fig. 4B). To determine if this preference for substrates was consistent regardless of varying substrate levels, different ratios of substrates were incubated with the respective enzymatic preparations; the findings are presented in Fig. 5, A and B. In the case of CrtZ from Alcaligenes PC-1, increasing the level of beta -carotene to a level three times greater than canthaxanthin did not alter the preference of the enzyme for the conversion of canthaxanthin to astaxanthin (Fig. 5A). In fact it appeared to some extent that such elevated levels of beta -carotene could inhibit the conversion of beta -carotene to zeaxanthin presumably by substrate inhibition. The A. aurantiacum CrtZ also showed no alteration in its preference for canthaxanthin conversion even when beta -carotene levels were increased six times greater than that of the canthaxanthin substrate (Fig. 5A). In contrast, only relatively small increases (1.5-3.0-fold) in canthaxanthin levels were required to eliminate completely the presence of zeaxanthin formation (Fig. 5A) by the CrtZ enzymes from either marine bacteria. The E. uredovora CrtZ was not studied extensively, but it was evident that increases in the proportion of canthaxanthin did alter comparatively the preference of the enzyme for the conversion of canthaxanthin to astaxanthin to some extent (Fig. 5A).


Fig. 4. Preferences of CrtZ (panel A) and W/BKT (panel B) in the presence of both utilizable substrates. Incubation conditions were identical to those described under "Experimental Procedures." Crude E. coli extracts had a protein content of 375 µg. Substrates (1.5 µg) were supplied in identical volumes. beta -CAR indicates beta -carotene; CAN, canthaxanthin; ZEA, zeaxanthin; AST, astaxanthin; and 4-KETO, 4-ketozeaxanthin. Data are presented as percent total activity correlating to rates of 401 pmol/h/mg of protein A. aurantiacum CrtZ (Agro), 210 pmol/h/mg of protein Alcaligenes PC-1 CrtZ (Al), and 510 pmol/h/mg of protein E. uredovora CrtZ (Erw). In panel B A. aurantiacum CrtW is equivalent to 210 pmol/h/mg protein Alcaligenes PC-1 CrtW 140 pmol/h/mg of protein, whereas H. pluvialis (BKT) is 210 pmol/h/mg of protein. These enzyme activities are the mean of duplicate or triplicate determinations from a typical experiment. Control incubations performed under identical conditions, but with heat-denatured extracts as well as extracts from E. coli strains not expressing crt genes, showed no activity.
[View Larger Version of this Image (27K GIF file)]



Fig. 5. Preferences of CrtZ (panel A) and W (panel B) with varying levels of both utilizable substrates. Incubations were performed in a manner identical to those described in Fig. 4, with the exception that the substrate ratios were varied; this was done by altering the volume of substrate extract added. The basal substrate level (i.e. ratio value 1) was 1 µg of carotenoid. Where no histogram bar is given, no activity was detected. In panel A, A and B indicate Alcaligenes PC-1 CrtZ with the substrates beta -carotene and canthaxanthin present in 1:2 and 3:1 ratios, respectively; total activity corresponds to 113 and 93 pmol/h/mg of protein, respectively. C and D refer to A. aurantiacum CrtZ beta -carotene and canthaxanthin 6:1 and 1:2 ratios, respectively; total activities are 438 and 450 pmol/h/mg of protein. E represents E. uredovora CrtZ; the beta -carotene and canthaxanthin ratio was 1:8; total activity was 500 pmol/h/mg of protein. Panel B letters represent Alcaligenes PC-1 CrtW. Substrate ratios for beta -carotene and zeaxanthin were 6:1 (A) and 1:3 (B); total activities were 60 and 21 pmol/h/mg of protein, respectively. C and D are A. aurantiacum CrtW at beta -carotene and zeaxanthin ratios of 6:1 and 1:2, respectively; total activity was 281 and 500 pmol/h/mg of protein, respectively. E shows the H. pluvialis BKT at a beta -carotene:zeaxanthin ratio of 1:2. The total activity was 213 pmol/h/mg of protein. Data represent typical experiments; determinations are the means of duplicate or triplicate incubations. Controls with denatured extracts as well as E. coli extracts not expressing the genes of interest were performed under identical conditions and showed no activity.
[View Larger Version of this Image (28K GIF file)]


The A. aurantiacum CrtW gene product showed a significant response to changes in substrate concentration, as when beta -carotene was in excess (6-fold) canthaxanthin was the product formed. When zeaxanthin was supplied to excess (2-fold) 4-ketozeaxanthin was formed preferentially (Fig. 5B). Comparison of the two situations suggested that the zeaxanthin to 4-ketozeaxanthin is the favored reaction as smaller incremental increases in substrate were required to result in a greater commitment to this reaction. The Alcaligenes PC-1 CrtW also showed an ability to respond to changes in precursor levels, as when beta -carotene was in excess canthaxanthin was the sole product formed, and when zeaxanthin levels were elevated 4-ketozeaxanthin resulted and canthaxanthin formation eliminated. Although not investigated to the same extent, BKT clearly responded to changes in precursor levels in a manner similar to that of the marine bacteria enzymes.

Collectively, data shown in Table I along with results determined in the presence of both utilizable substrate in equal (Fig. 4) and varying concentrations (Fig. 5), indicate that the marine bacteria CrtZ enzymes significantly favor performing the conversion of canthaxanthin to astaxanthin, whereas the Erwinia CrtZ has a recognizable preference for converting beta -carotene to zeaxanthin. In some respects this is not too surprising considering that the Erwinia species accumulate zeaxanthin or its glucoside but no ketocarotenoids endogenously. In vivo complementation studies have established that both varieties of enzyme have the potential to perform identical reactions (15). The CrtW/BKT enzymes are significantly less selective in their substrate preference compared with the CrtZ enzymes. When equal ratios of substrates are used the enzymes utilization is similar; but compared with the CrtZ enzymes only small elevations of zeaxanthin or beta -carotene substrates are required to alter the product profile to 4-ketozeaxanthin or canthaxanthin, respectively.

Based on the enzymes' substrate utilization we predict that the astaxanthin pathway in marine bacteria occurs ideally through the initial formation of canthaxanthin via echinenone, which is then acted upon by CrtZ enzymes to form astaxanthin. This proposal is based on the facts that beta -carotene is the initial precursor to oxygenated carotenoids, and the marine bacteria CrtZ favors the conversion of canthaxanthin to astaxanthin in vitro. However, the bifunctional nature of the enzymes must be taken into account, and therefore if zeaxanthin is formed initially either due to environmental influences or in the case of recombinant studies altered expression levels, the CrtW/BKT enzymes will utilize this as a substrate-forming 4-ketozeaxanthin, which will accumulate because of the enzyme's apparent ineffectiveness to convert 4-ketozeaxanthin to astaxanthin. In the recent publication by Yokoyama and Miki (33), the astaxanthin pathway was proposed from the accumulation of intermediates under different culture conditions. The study indicated that when zeaxanthin was formed, substantial 4-ketozeaxanthin also accumulated, a finding supporting the pathway deduced from the capabilities of the enzymes determined in vitro. Other pathways to astaxanthin via hydroxyechinenone intermediates must await further assay development before they can be confirmed. The similarities of BKT to the CrtW enzymes would suggest that the pathway in Haematococcus is like the marine bacteria, as suggested in previous in vivo studies (34), but the yet to be isolated hydroxylase gene from this organism prevents confirmation.

Concluding Remarks

The in vitro characterization of astaxanthin biosynthetic enzymes described in this article provides the first enzymological data on their substrate utilization and product diversity as well as possible cofactor requirements. The data presented indicate that the CrtZ-type enzymes show properties of enzymes frequently categorized as hydroxylases, and CrtW-type enzymes, oxygenases. Both are also bifunctional with regard to substrates containing beta -ionone rings. It is for these reasons that we propose that the enzymes be referred to as 3,(3')-beta -ionone ring hydroxylase and 4,(4')-beta -ionone ring oxygenase as standard enzyme nomenclature.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    On leave from Biochemistry Division, Royal Holloway University of London, Egham, Surrey, TW20 OEX, U. K. To whom correspondence should be addressed: Central Laboratories for Key Technology, Kirin Brewery Co., Ltd., 1-13-5, Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236, Japan. Tel.: 81-45-788-7209; Fax: 81-45-788-4042.
1   The abbreviation used is: HPLC, high performance liquid chromatography.

Acknowledgments

We are grateful to the members of the Kirin Metabolic Engineering group and Dr. S. Ferri for helpful discussion. We also thank Dr. David E. Cane of Brown University for advice regarding possible CrtZ/W enzymatic mechanisms.


REFERENCES

  1. Matsuno, T. (1989) in Carotenoids: Chemistry and Biology (Krinsky, N. I., Mathews-Roth, M. M., and Taylor, F., eds), pp. 59-74, Plenum Publishing Corp., New York
  2. Renstrom, B., Borch, G., and Liaaen-Jensen, S. (1981) Helv. Chim. Acta 64, 449-453
  3. Torrissen, O. J., Hardy, R. W., and Shearer, K. D. (1989) Crit. Rev. Aquatic Sci. 1, 209-213
  4. Miki, W., Otaki, N., Yokoyama, A., Izumida, H., and Shimidzu, N. (1994) Experientia (Basel) 50, 684-686
  5. Fujita, T., Satake, M., Watanabe, T., Kitajima, C., Takeda, M., Shimeno, S., Kuwabara, H., Miki, W., Yamaguchi, K., and Konosu, S. (1983) Bull. Japan. Soc. Sci. Fish. 49, 1855-1861
  6. Johnson, E. A., and An, G. H. (1991) Crit. Rev. Biotechnol. 11, 297-326
  7. Matsuno, T. (1991) Pure Appl. Chem. 63, 81-88
  8. Tanaka, T., Morishita, Y., Suzui, M., Kojima, T., Okumura, A., and Mori, H. (1994) Carcinogenesis 15, 15-19 [Abstract]
  9. Jyonouchi, H., Zhang, L., and Tomita, Y. (1993) Nutr. Cancer 19, 269-278 [Medline] [Order article via Infotrieve]
  10. Miki, W., Otaki, N., Shimidzu, N., and Yokoyama, A. (1994) J. Mar. Biotechnol. 2, 35-37
  11. Miki, W. (1991) Pure Appl. Chem. 63, 141-146
  12. Andrewes, A. G., Phaff, H. J., and Starr, M. P. (1976) Phytochemistry 15, 1003-1007 [CrossRef]
  13. Boussiba, S., and Vonshak, A. (1991) Plant Cell Physiol. 32, 1077-1082
  14. Yokoyama, A., Izumida, H., and Miki, W. (1994) Biosci. Biotech. Biochem. 58, 1842-1844
  15. Misawa, N., Satomi, Y., Kondo, K., Yokoyama, A., Kajiwara, S., Saito, T., Ohtani, T., and Miki, W. (1995) J. Bacteriol. 177, 6575-6584 [Abstract]
  16. Misawa, N., Nakagawa, M., Kobayashi, K., Yamano, S., Izawa, Y., Nakamura, K., and Harashima, K. (1990) J. Bacteriol. 172, 6704-6712 [Medline] [Order article via Infotrieve]
  17. Hundle, B. S., O'Brien, D. A., Beyer, P., Kleinig, H., and Hearst, J. E. (1993) FEBS Lett. 315, 329-334 [CrossRef][Medline] [Order article via Infotrieve]
  18. Misawa, N., Kajiwara, S., Kondo, K., Yokoyama, A., Satomi, Y., Saito, T., Miki, W., and Ohtani, T. (1995) Biochem. Biophys. Res. Commun. 209, 867-876 [CrossRef][Medline] [Order article via Infotrieve]
  19. Kajiwara, S., Kakizono, T., Saito, T., Kondo, K., Ohtani, T., Nishio, N., Nagi, S., and Misawa, N. (1995) Plant Mol. Biol. 29, 343-352 [Medline] [Order article via Infotrieve]
  20. Bramley, P. M. (1985) Adv. Lipid Res. 21, 243-279
  21. Fraser, P. D., de las Rivas, J., Mackenzie, A., and Bramley, P. M. (1991) Phytochemistry 22, 441-445 [CrossRef]
  22. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Vol. 3, Appendix 3, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  23. Sandmann, G., and Bramley, P. M. (1985) Biochim. Biophys. Acta 843, 73-77
  24. Britton, G. (1985) Methods Enzymol. 111, 113-149 [Medline] [Order article via Infotrieve]
  25. Funk, C., and Croteau, R. (1993) Plant Physiol. 101, 1231-1237 [Abstract/Free Full Text]
  26. Funk, C., and Croteau, R. (1994) Arch. Biochem. Biophys. 308, 258-266 [CrossRef][Medline] [Order article via Infotrieve]
  27. McDermott, J. B. C., Brown, D. J., Britton, G., and Goodwin, T. W. (1974) Biochem. J. 144, 231-243 [Medline] [Order article via Infotrieve]
  28. Yamamoto, H. Y., Chichester, C. O., and Nakayama, T. O. (1962) Arch. Biochem. Biophys. 96, 645-649 [Medline] [Order article via Infotrieve]
  29. Schroeder, W. A., and Johnson, E. A. (1995) J. Biol. Chem. 270, 18374-18379 [Abstract/Free Full Text]
  30. Dawson, G. W., Hick, A. J., Bennett, R. N., Donald, A., Pickett, J. A., and Wallsgrove, R. M. (1993) J. Biol. Chem. 268, 27154-27159 [Abstract/Free Full Text]
  31. Lange, T., Schweimer, A., Ward, D., Hedden, P., and Graebe, J. E. (1994) Planta 195, 98-107
  32. Heinz, E. (1993) in Lipid Metabolism in Plants (Moore, T. S, ed), pp. 33-89, CRC Press, Boca Raton, FL
  33. Yokoyama, A., and Miki, W. (1995) FEMS Microbiol. Lett. 128, 139-144 [CrossRef]
  34. Fan, L., Vonshak, A., Gabby, R., Hirshberg, J., Cohen, Z., and Boussiba, S. (1995) Plant Cell Physiol. 36, 1519-1524
  35. Sandmann, G. (1992) in Target Assays for Modern Herbicides and Related Phytotoxic Compounds (Boger, P., and Sandmann, G., eds), pp. 9-13, Lewis Publishers/CRC Press, Boca Raton, FL

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.